Moderna's Q1 2026 Earnings Outlook and Financial Performance
Moderna, Inc. (MRNA) is set to report its Q1 2026 earnings on May 1, with analysts expecting a loss of $2.27 per share, a slight decline from the previous year. The company has consistently exceeded earnings estimates in recent quarters and has seen significant stock price growth over the past year. The stock has outperformed major indices like the S&P 500 and XLV.
Topics: Biotechnology Earnings Financial Performance Market Expectations Moderna